Methylphenidate enhances inhibitory synaptic transmission by increasing the content of norepinephrine in the locus coeruleus of juvenile rats

Kurume Medical Journal

Volumn 57, Issue 1-2, 2010, Pages 29-38

  Kidani, Yuri ^a   Ishimatsu, Masaru ^a   Akasu, Takashi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ADHD; IPSC; Juvenile rats; Locus coeruleus; Methylphenidate; NE transmission; Norepinephrine transporter; Outward current

Indexed keywords

AMINO ACID; METHYLPHENIDATE; NORADRENALIN; POTASSIUM ION; YOHIMBINE;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL POLARITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; HYPERPOLARIZATION; INTRACELLULAR RECORDING; ION CURRENT; JUVENILE ANIMAL; LOCUS CERULEUS; MALE; MICROELECTRODE; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; PATCH CLAMP; POSTSYNAPTIC INHIBITION; RAT; SYNAPTIC TRANSMISSION; WHOLE CELL;

EID: 78149482241     PISSN: 00235679     EISSN: 18812090     Source Type: Journal    
DOI: 10.2739/kurumemedj.57.29     Document Type: Article

References (39)

1. Seeman P, and Madras B. Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis. Behav Brain Res 2002; 130:79-83.
2. Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 1998; 94:127-152.
3. Ferguson SA. A review of rodent models of ADHD. In: Stimulant Drugs and ADHD, Basic and Clinical Neuroscience, ed. Solanto MV, Arnsten AFT, and Castellanos FX, Oxford University Press, New York, pp 209-220, 2001.
4. Arnsten AFT. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology 2006; 31:2376-2383.
5. Pliszka SR, McCracken JT, and Maas JW. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 1996; 35:264-272.
6. Popper CW. Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000; 9:605-646.
7. Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001; 158:1067-1074.
8. Coull JT, Jones MEP, Egan TD, Frith CD, and Maze M. Attentional effects of noradrenaline vary with arousal level: selective activation of thalamic pulvinar in humans. NeuroImage 2004; 22:315-322.
9. Smith A, and Nutt D. Noradrenaline and attention lapses. Nature 1996; 380:291.
10. Biederman J, and Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 1999; 46:1234-1242.
11. Davids E, Zhang K, Tarazi FI, and Baldessarini RJ. Animal models of attention-deficit hyperactivity disorder. Brain Res Rev 2003; 42:1-21.
12. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AFT, Kelley AE et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006; 60:1111-1120.
13. Amaral DG, and Sinnamon HM. The locus coeruleus: neurobiology of a central noradrenergic nucleus. Prog Neurobiol 1977; 9:147-196.
14. Moore RY, and Bloom FE. Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci 1979; 2:113-168.
15. Foote SL, Aston-Jones G, and Bloom FE. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc Natl Acad Sci USA 1980; 77:3033-3037.
16. Olpe HR, Steinmann MW, and Jones RSG. Locus coeruleus as a target for psychogeriatric agents. Ann NY Acad Sci 1985; 444:394-405.
17. Aston-Jones G, Rajkowski J, and Cohen J. Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 1999; 46:1309-1320.
18. Lacroix D, and Ferron A. Electrophysiological effects of methylphenidate on the coeruleo-cortical noradrenergic system in the rat. Eur J Pharmacol 1988; 149:277-285.
19. Ishimatsu M, Kidani Y, Tsuda A, and Akasu T. Effects of methylphenidate on the membrane potential and current in neurons of the rat locus coeruleus. J Neurophysiol 2002; 87:1206-1212.
20. Kidani Y, Ishimatsu M, Kuwahata T, Yamashita Y, Akasu T et al. Effects of milnacipran on neuronal excitability and synaptic transmission in neurons of the rat locus coeruleus. No To Hattatsu 2005; 37:31-38. (in Japanese)
21. Egan TM, Henderson G, North RA, and Williams JT. Noradrenaline-mediated synaptic inhibition in rat locus coeruleus neurones. J Physiol 1983; 345:477-488.
22. Kidani Y, Ishimatsu M, Kuwahata T, and Akasu T. Methylphenidate enhances the noradrenergic effects on locus coeruleus neurons of the juvenile rat. Jpn J Physiol 2004; 54:S149.
23. Ishimatsu M, and Williams JT. Synchronous activity in locus coeruleus results from dendritic interactions in pericoerulear regions. J Neurosci 1996; 16:5196-5204.
24. Surprenant A, and Williams JT. Inhibitory synaptic potentials recorded from mammalian neurones prolonged by blockade of noradrenaline uptake. J Physiol 1987; 382:87-103.
25. North RA. Drug receptors and the inhibition of nerve cells. Br J Pharmacol 1989; 98:13-28.
26. Williams JT, Henderson G, and North RA. Characterization of α2-adrenoceptors which increase potassium conductance in rat locus coeruleus neurones. Neuroscience 1985; 14:95-101.
27. Hendley ED, and Fan XM. Regional differences in brain norepinephrine and dopamine uptake kinetics in inbred rat strains with hypertension and/or hyperactivity. Brain Res 1992; 586:44-52.
28. Ikeura S, Kidani Y, Ishimatsu M, and Akasu T. Norepinephrine content was increased in locus coeruleus and medial prefrontal cortex of spontaneously hypertensive rats (SHR), AD/HD model rat. J Physiol Sci 2006; 56: S173.
29. Maeda T, and Gerebtzoff MA. On the development of locus ceruleus. 2. Histoenzymatic study. Acta Neurol Psychiatr Belg 1969; 69:11-19.
30. Sanders JD, Happe HK, Bylund DB, and Murrin LC. Development of the norepinephrine transporter in the rat CNS. Neuroscience 2005; 130:107-117.
31. Curet O, and de Montigny C. Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. III. Evidence for the physiological role of terminal α2-adrenergic autoreceptors. Brain Res 1989; 499:18-26.
32. Williams JT, and North RA. Catecholamine inhibition of calcium action potentials in rat locus coeruleus neurones. Neuroscience 1985; 14:103-109.
33. Aston-Jones G, Rajkowski J, Kubiak P, and Alexinsky T. Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task. J Neurosci 1994; 14:4467-4480.
34. Aston-Jones G, Rajkowski J, and Cohen J. Locus coeruleus and regulation of behavioral flexibility and attention. Prog Brain Res 2000; 126:165-182.
35. Aston-Jones G, and Cohen JD. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci 2005; 28:403-450.
36. Dalley JW, Cardinal RN, and Robbins TW. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 2004; 28:771-784.
37. Lapiz MDS, and Morilak DA. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 2006; 137:1039-1049.
38. Bunsey MD, and Strupp BJ. Specific effects of idazoxan in a distraction task: evidence that endogenous norepinephrine plays a role in selective attention in rats. Behav Neurosci 1995; 109:903-911.
39. Devauges V, and Sara SJ. Activation of the noradrenergic system facilitates an attentional shift in the rat. Behav Brain Res 1990; 39:19-28.